Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Mayo Clinic experts available to discuss latest colorectal cancer research and treatment

March is National Colorectal Cancer Awareness Month. Colon cancer is one of the most common and deadly cancers, and also one of the most preventable. Mayo Clinic experts are available to discuss the latest in colorectal cancer research, detection and treatment.

6 Mar 2012

Congress urged to pass 'Removing Barriers to Colorectal Cancer Screening Act of 2012'

Colonoscopy for colorectal cancer screening saves lives, but a loophole in current Medicare law may cause patients to think twice before undergoing this vital test. Legislation introduced today seeks to ensure that colorectal cancer screening for all Medicare beneficiaries is free, as intended.

2 Mar 2012

Gastroenterologists provide five facts to reduce colon cancer risk

The number two cancer killer in the U.S. is often preventable and highly curable. "It's important for people to understand that, with proper screening, colon cancer can not only be detected early, but often can be prevented from developing," says Dr. Felice Schnoll-Sussman, a gastroenterologist and acting director of The Jay Monahan Center for Gastrointestinal Health at NewYork-Presbyterian/Weill Cornell Medical Center.

2 Mar 2012

Collaborative study of physical activity patterns, eating habits in colorectal cancer patients

The five hospitals of Meridian Health, a System Partner of The Cancer Institute of New Jersey (CINJ), have joined forces with CINJ in offering a clinical research study that examines physical activity patterns and eating habits in colorectal cancer patients who have recently finished treatment.

27 Feb 2012

FDA clears invendo medical's new C20 colonoscopy system

invendo medical announced today that the company received 510(k) clearance by the U.S. Food and Drug Administration of the company's new C20 colonoscopy system including the SC20 single-use colonoscope.

24 Feb 2012

Higher alcohol intake may increase risk of CRC among obese people

A case-control study from Newfoundland/Labrador has reported that greater alcohol intake may increase the risk of colorectal cancer (CRC) among obese subjects, but not among non-obese subjects.

24 Feb 2012

Colonoscopy reduces mortality from colorectal cancer

For the first time, a new study has shown that removing polyps by colonoscopy not only prevents colorectal cancer from developing, but also prevents deaths from the disease. Patients in the study were evaluated for up to 23 years after having the procedure, providing the longest follow-up results to date.

23 Feb 2012

Viewpoints: A missing contraception question, Obama's budget blind spot, NEJM on Medicare Advantage

David Brooks and Gail Collins discuss the surprising role debates over contraception, abortion and unwed mothers have played so far in the campaign.

23 Feb 2012

Colonoscopy prevents cancer deaths: Study

A new study shows that colonoscopy actually prevents cancer deaths. Although many people have assumed that colonoscopy must save lives because it is so often recommended, strong evidence has been lacking until now.

23 Feb 2012

Inven2, OGT enter license agreement for 12 colorectal cancer biomarkers

Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, announced today that it has entered into an exclusive licensing agreement with Inven2, the technology transfer office at Oslo University Hospital (OUS) and University of Oslo (UiO), for 12 highly promising colorectal cancer tissue biomarkers.

From Oxford Gene Technology 23 Feb 2012

CT colonography effective in diagnosing colorectal cancer in adults over 65

Computed tomography (CT) colonography can be used as a primary screening tool for colorectal cancer in adults over the age of 65, according to a new study published online in the journal Radiology.

23 Feb 2012

Study confirms efficacy of CT Colonography as a front line colorectal cancer screening tool

Computerized tomographic (CT) colonography (CTC), also known as virtual colonoscopy, is comparable to standard colonoscopy in its ability to accurately detect cancer and precancerous polyps in people ages 65 and older, according to a paper published online today in Radiology.

23 Feb 2012

Americans used less health care during recent U.S. economic recession

The recent U.S. economic recession was the longest and most severe since World War II. During this period, personal spending on health care grew at the slowest rate in over 50 years, suggesting that Americans used less health care.

22 Feb 2012

NYSDOH approves Enzo Biochem's ColonSentry test

Enzo Biochem, Inc. today announced that the New York State Department of Health has approved Enzo Clinical Labs' use of the ColonSentry test for providing an assessment of a patient's risk of having colorectal cancer.

22 Feb 2012

Indiana CTSI HUB offers open-source software to accelerate clinical and translational research

At a time when medical research increasingly requires collaboration by large numbers of busy people, the Indiana Clinical and Translational Science Institute HUB offers a model for using advanced information technology to link scientists, health providers, community partners and others for the purpose of accelerating clinical and translational research.

20 Feb 2012

Nordion celebrates first anniversary of market launch of TheraSphere

Nordion Inc., a leading provider of products and services to the global health science market, today celebrated the first anniversary of the market introduction of TheraSphere, an innovative radioembolic liver cancer therapy, in the Republic of Turkey.

17 Feb 2012

Thrombocytosis linked to severity of ovarian cancer

Highly elevated platelet levels fuel tumor growth and reduce the survival of ovarian cancer patients, an international team of researchers led by scientists at The University of Texas MD Anderson Cancer center reports in the New England Journal of Medicine.

16 Feb 2012

Pyromaker can rapidly sequence cancer-driving mutations

Using precise information about an individual's genetic makeup is becoming increasingly routine for developing tailored treatments for breast, lung, colon and other cancers. But techniques used to identify meaningful gene mutations depend on analyzing sequences of both normal and mutant DNA in tumor samples, a process that can yield ambiguous results. Now, a team of Johns Hopkins researchers says it has developed an easy-to-use online computer software application that can clear up any confusion faster and cheaper than other methods currently used to do the job.

16 Feb 2012

Gen-Probe receives FDA approval for PROGENSA PCA3 assay

DiagnoCure, Inc., a Quebec life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that the US Food and Drug Administration (FDA) has approved Gen-Probe's PROGENSA PCA3 (Prostate Cancer Antigen 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.

15 Feb 2012

Study confirms increased risk of cancers linked with Lynch syndrome

People with Lynch syndrome have a genetic mutation that gives them a high risk of several types of cancer including bowel cancer. The genes that are damaged can't repair any errors that occur in our DNA.

15 Feb 2012